Advertisement

Advertisement

AU:MYX Stock Latest News

Mayne Pharma Moves to Replace Retiring Non-Executive Director

Company AnnouncementsMayne Pharma Moves to Replace Retiring Non-Executive Director

Citigroup Group Ceases to Be Substantial Holder in Mayne Pharma

PremiumCompany Announcements

Citigroup Group Ceases to Be Substantial Holder in Mayne Pharma

13d ago

Mayne Pharma to Showcase Women’s Health, Dermatology Progress at ASX SMIDcaps Conference

PremiumCompany Announcements

Mayne Pharma to Showcase Women’s Health, Dermatology Progress at ASX SMIDcaps Conference

20d ago

Citi Group Entities Cease to Be Substantial Holders in Mayne Pharma

PremiumCompany Announcements

Citi Group Entities Cease to Be Substantial Holders in Mayne Pharma

21d ago

Mayne Pharma to Highlight Growth Strategy at ASX SMIDcaps Conference

PremiumCompany Announcements

Mayne Pharma to Highlight Growth Strategy at ASX SMIDcaps Conference

28d ago

Mayne Pharma Showcases DistributeRx U.S. Launch in Investor Briefing

PremiumCompany AnnouncementsMayne Pharma Showcases DistributeRx U.S. Launch in Investor Briefing

1M ago

Mayne Pharma launches DistributeRx to drive direct-to-patient U.S. growth

Company Announcements

Mayne Pharma launches DistributeRx to drive direct-to-patient U.S. growth

1M ago

S&P Dow Jones Indices Unveils March 2026 Rebalance of S&P/ASX Benchmarks

Company Announcements

S&P Dow Jones Indices Unveils March 2026 Rebalance of S&P/ASX Benchmarks

1M ago

Mitsubishi UFJ Financial Group exits substantial holder position in Mayne Pharma

PremiumCompany Announcements

Mitsubishi UFJ Financial Group exits substantial holder position in Mayne Pharma

1M ago

Mayne Pharma Discloses Exit of Director Patrick Blake and His Share Interests

PremiumCompany Announcements

Mayne Pharma Discloses Exit of Director Patrick Blake and His Share Interests

1M ago

First Sentier Group Exits Substantial Shareholding in Mayne Pharma

PremiumCompany Announcements

First Sentier Group Exits Substantial Shareholding in Mayne Pharma

2M ago

Mayne Pharma Earnings Call Balances Growth And Risk

PremiumCompany Announcements

Mayne Pharma Earnings Call Balances Growth And Risk

2M ago

Mayne Pharma Plans New Performance Rights Issue

PremiumCompany AnnouncementsMayne Pharma Plans New Performance Rights Issue

2M ago

Mayne Pharma Discloses Equity Holdings as Director Shawn O’Brien Departs Board

Company Announcements

Mayne Pharma Discloses Equity Holdings as Director Shawn O’Brien Departs Board

2M ago

Mayne Pharma Frames 1H FY26 Results Around EBITDA and Disclosure Transparency

Company Announcements

Mayne Pharma Frames 1H FY26 Results Around EBITDA and Disclosure Transparency

2M ago

Mayne Pharma lifts margins as dermatology outperforms despite softer cash flow

PremiumCompany Announcements

Mayne Pharma lifts margins as dermatology outperforms despite softer cash flow

2M ago

Vanguard Group Cuts Stake Below Substantial Holder Threshold in Mayne Pharma

PremiumCompany Announcements

Vanguard Group Cuts Stake Below Substantial Holder Threshold in Mayne Pharma

2M ago

Mayne Pharma Secures Shareholder Backing for Board, Pay and CEO Incentives at AGM

PremiumCompany Announcements

Mayne Pharma Secures Shareholder Backing for Board, Pay and CEO Incentives at AGM

2M ago

Mayne Pharma Opens Delayed 2025 AGM After Cosette Scheme Setback

PremiumCompany Announcements

Mayne Pharma Opens Delayed 2025 AGM After Cosette Scheme Setback

2M ago

Goldman Sachs Ceases to Be Substantial Shareholder in Mayne Pharma

PremiumCompany AnnouncementsGoldman Sachs Ceases to Be Substantial Shareholder in Mayne Pharma

3M ago

Mayne Pharma to Vigorously Contest Cosette Appeal Over FY25 Metrics

Company Announcements

Mayne Pharma to Vigorously Contest Cosette Appeal Over FY25 Metrics

3M ago

Mayne Pharma Director Frank Condella Steps Down from Board

Company Announcements

Mayne Pharma Director Frank Condella Steps Down from Board

3M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >